Developing an HEOR evidence generation strategy to support product launch

Situation

A biopharmaceutical client developing two early Phase 2 assets had yet to build out an HEOR team or evidence generation strategy to support their commercial launch.  Development of an evidence generation strategy was needed to support successful commercial launches in the next five years.

Solution

We built a comprehensive roadmap grounded in primary and secondary research. Our team evaluated gaps in existing research, conducted payer and provider interviews to assess evidence needs for coverage, reimbursement, and uptake, and charted appropriate evidence generation plan to address access barriers.

Success

The company is now relying on the evidence generation plan as a roadmap to coordinate all HEOR-related launch activities and position their products competitively in the marketplace.